Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer

NCT02125019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2023-02-27

No results posted yet for this study

Summary

Longitudinal Evaluation of Taxane induced neuropathy in early stage breast cancer.

Conditions

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Nicole Williams, MD · Ohio State University Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-04
Primary Completion
2018-05-14
Completion
2018-05-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02125019 on ClinicalTrials.gov